Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Dosing time affects finasteride's effectiveness and safety in rats.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Using minoxidil with finasteride in a cream helps maintain hair thickness after stopping oral finasteride.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.